Besides, accumulating evidence have demonstrated that MAPK activation aggravates lung inflammation of ARDS by upregulating the activity of NLRP3 inflammasome and NF-κB in animal models [100–102]. This evidence concerns the gene NFKB1 and acute respiratory distress syndrome.